SHROTRIYA RAJESH C MD 4
4 · CASI Pharmaceuticals, Inc. · Filed May 26, 2022
Insider Transaction Report
Form 4
SHROTRIYA RAJESH C MD
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-25+345,806→ 345,806 totalExercise: $0.47Exp: 2032-05-25→ Common Stock (345,806 underlying)
Footnotes (1)
- [F1]Stock option award will vest ratably quarterly to the end of the year.